Paris, France and Cambridge, MA, USA, 16 april, 2024, Ariana Pharma, a leading Artificial Intelligence drug development company, announced today that it has entered a €3 million consortium sponsored by the Eurostars 3 program, led by ONA Therapeutics SL, specialized in the discovery and development of biologics targeting advanced cancer, and in collaboration with Crown Bioscience, and oloBion. To know more
